Soligenix expands European medical board for lymphoma drug approval push

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/3/2026

1. SNOW
2. AVGO
3. RARE
4. HPE
5. FIVE
6. SPY
7. VRTS
8. NTAP
9. NTSK
10. OLLI

Go back to Soligenix expands European medical board for lymphoma drug approval push
Soligenix, Inc. (NASDAQ: SNGX) Delayed: 0.38 --0 (-0%)
Previous Close $0.38    52 Week High $4.35 
Open $0.39    52 Week Low $0.44 
Day High $0.39    P/E N/A 
Day Low $0.38    EPS $-0.81 
Volume 59,965